Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients
Clinical trial NCT04863885 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04863885
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-30
- Primary completion
- 2025-09-12
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.